President Donald Trump said his administration will make an announcement next week about dropping prescription drug prices "really substantially," according to Reuters.
Pharmacy
Despite strong growth in its retail pharmacy business, CVS Health ended the second quarter with a $2.56 billion loss, according to a recently released earnings report.
CMS will give private Medicare Advantage plans more negotiating power over prices for Part B drugs, which are administered in physician offices and hospitals, in an effort to reduce spending, according to an Aug. 7 news release.
People care about big pharma's actions — especially as the industry faces heightened political pressure to lower prescription drug prices and intensified scrutiny about pricing strategies. While the public knows many of the top dogs by name, there are other…
Several major pharmaceutical companies recently shut down their antibiotic and antiviral research projects, backing away from the growing threat of superbugs, which may kill more than 10 million people a year by 2050.
Advertisement
Sun Pharmaceutical Industries issued a recall of 5,215 units of testosterone cypionate injections in the U.S., according to the Economic Times.
Canonsburg, Pa.-based Mylan argues the U.S. is wasting billions of dollars on name brand anti-HIV drugs, instead of making generic alternatives, according to Science.
Allergan filed a lawsuit against Pfizer Aug. 2 that would require the company to cover damages associated with several lawsuits brought against Allergan that allege it improperly marketed and sold an opioid that Allergan had acquired from a company Pfizer…
Teva Pharmaceuticals, the world's largest generic drugmaker, saw its second-quarter revenue decline 18 percent to $4.7 billion — suggesting its financial woes have not passed, The Wall Street Journal reports.
There is a new piece of hardware pharmaceutical CEOs can bring home — a trophy for being the "Most Hated Pharma CEO of the Year," according to a STAT newsletter.